Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:country |
gptkb:France
|
| gptkbp:focus |
supportive care
antifungal therapies orphan oncology products |
| gptkbp:formerName |
Onxeo
|
| gptkbp:founded |
1997
|
| gptkbp:headquarters_location |
gptkb:Paris
|
| https://www.w3.org/2000/01/rdf-schema#label |
BioAlliance Pharma
|
| gptkbp:industry |
gptkb:drug
|
| gptkbp:keyPerson |
Judith Greciet
|
| gptkbp:product |
gptkb:Sitavig
Livatag Loramyc |
| gptkbp:publiclyTraded |
gptkb:Euronext_Paris
|
| gptkbp:website |
https://www.onxeo.com/
|
| gptkbp:bfsParent |
gptkb:Sitavig
|
| gptkbp:bfsLayer |
7
|